JENNIFER HUNTER: Open Payments
NPI 1356960777 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 18 payments from 6 companies in 2025. Trend: 2023 $351 · 2024 $328 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $124 |
| Lilly USA, LLC | 4 | $77 |
| Novo Nordisk Inc | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| PFIZER INC. | 1 | $20 |
Products named: OTEZLA, MOUNJARO, EVENITY, NEXLETOL, SHINGRIX, Ozempic, PREVNAR 20, Wegovy.
Industry payments across MS — which companies pay providers there.
